Linjun Hu

799 total citations
28 papers, 482 citations indexed

About

Linjun Hu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Linjun Hu has authored 28 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Linjun Hu's work include Cancer Immunotherapy and Biomarkers (6 papers), Prostate Cancer Treatment and Research (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Linjun Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Prostate Cancer Treatment and Research (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Linjun Hu collaborates with scholars based in China and United States. Linjun Hu's co-authors include Qiuran Xu, Zunqiang Xiao, Qiaojuan Zhu, Dongsheng Huang, Yang Guo, Qiliang Lu, Junjun Zhao, Xiangmin Tong, Zhan Shi and Yang Liu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Journal of Magnetism and Magnetic Materials.

In The Last Decade

Linjun Hu

25 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linjun Hu China 13 250 211 113 98 89 28 482
Zunqiang Xiao China 13 242 1.0× 205 1.0× 99 0.9× 95 1.0× 97 1.1× 33 512
Yifei Mu China 14 228 0.9× 133 0.6× 140 1.2× 94 1.0× 46 0.5× 27 457
Li Zuo China 13 252 1.0× 127 0.6× 93 0.8× 110 1.1× 118 1.3× 35 451
Yao-fei Pei China 11 334 1.3× 175 0.8× 101 0.9× 48 0.5× 76 0.9× 13 474
Shifeng Xu China 12 239 1.0× 177 0.8× 143 1.3× 50 0.5× 109 1.2× 22 456
Xiaopin Ji China 15 301 1.2× 183 0.9× 197 1.7× 69 0.7× 95 1.1× 31 584
Xueqing Yao China 13 360 1.4× 230 1.1× 210 1.9× 118 1.2× 103 1.2× 51 635
Jong‐Sun Choi South Korea 14 322 1.3× 122 0.6× 189 1.7× 61 0.6× 74 0.8× 20 565
Ninghua Yao China 13 331 1.3× 266 1.3× 117 1.0× 68 0.7× 79 0.9× 43 516
Teruhide Ishigame Japan 12 197 0.8× 132 0.6× 141 1.2× 66 0.7× 101 1.1× 36 406

Countries citing papers authored by Linjun Hu

Since Specialization
Citations

This map shows the geographic impact of Linjun Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjun Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjun Hu more than expected).

Fields of papers citing papers by Linjun Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linjun Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjun Hu. The network helps show where Linjun Hu may publish in the future.

Co-authorship network of co-authors of Linjun Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Linjun Hu. A scholar is included among the top collaborators of Linjun Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linjun Hu. Linjun Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Lv, Dan, Yiqun Li, Liyan Huang, et al.. (2023). Inflammatory Biomarkers in Assessing Severity and Prognosis of Immune Checkpoint Inhibitor-Associated Cardiotoxicity. ESC Heart Failure. 10(3). 1907–1918. 12 indexed citations
5.
Shang, Bingqing, Xingang Bi, Yan Song, et al.. (2023). Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma. Cancer Medicine. 12(24). 21807–21819. 5 indexed citations
6.
Yang, Zhenrong, Linjun Hu, Guoliang Li, et al.. (2022). Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis. Translational Andrology and Urology. 11(6). 803–813. 8 indexed citations
7.
Yang, Zhenrong, Linjun Hu, Guoliang Li, et al.. (2022). Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study. EClinicalMedicine. 43. 101161–101161. 16 indexed citations
8.
Zeng, Zhi, Qiliang Lu, Yang Liu, et al.. (2021). Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 641522–641522. 27 indexed citations
10.
Zhang, Qiang, et al.. (2021). A flexible magnetic field sensor based on paramagnetic C60@Fe3O4 nanocomposites and ordered hexagonally structured substrate. Journal of Magnetism and Magnetic Materials. 537. 168171–168171. 3 indexed citations
11.
Xiao, Zunqiang, Linjun Hu, Liu Yang, et al.. (2020). TGFβ2 is a prognostic‐related biomarker and correlated with immune infiltrates in gastric cancer. Journal of Cellular and Molecular Medicine. 24(13). 7151–7162. 43 indexed citations
12.
Xiao, Zunqiang, Yang Liu, Junjun Zhao, et al.. (2020). Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis. International Journal of Biological Sciences. 16(13). 2296–2305. 28 indexed citations
13.
Shi, Zhan, Zunqiang Xiao, Linjun Hu, et al.. (2020). The genetic association between type 2 diabetic and hepatocellular carcinomas. Annals of Translational Medicine. 8(6). 380–380. 10 indexed citations
14.
Hu, Linjun, Junjun Zhao, Yang Liu, et al.. (2020). Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis. International Journal of Medical Sciences. 17(17). 2735–2743. 17 indexed citations
15.
Hu, Linjun, Zhan Shi, Yang Liu, et al.. (2019). DNA methylation-based prognostic biomarkers of acute myeloid leukemia patients. Annals of Translational Medicine. 7(23). 737–737. 24 indexed citations
16.
Guo, Yang, Zunqiang Xiao, Yang Liu, et al.. (2019). Hypoxia‑inducible factors in hepatocellular carcinoma (Review). Oncology Reports. 43(1). 3–15. 76 indexed citations
17.
Guo, Yang, Bowen Yao, Qiaojuan Zhu, et al.. (2019). MicroRNA‐301b‐3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Journal of Cellular and Molecular Medicine. 23(8). 5037–5047. 28 indexed citations
18.
Xiao, Zunqiang, Zhan Shi, Linjun Hu, et al.. (2019). A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Annals of Translational Medicine. 7(23). 738–738. 33 indexed citations
19.
Zhu, Qiaojuan, Yazhao Li, Yang Guo, et al.. (2019). Long non‐coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B‐cell lymphoma cells by targeting miR‐497‐5p/PIM1 axis. Journal of Cellular and Molecular Medicine. 23(11). 7395–7405. 43 indexed citations
20.
Hu, Linjun, et al.. (2017). Modified docetaxel regimen for prostate cancer patients who got poor tolerance to chemotherapy. Zhonghua miniao waike zazhi. 38(8). 615–618. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026